Will Amgen, Already Above Its 50-Day Line, Break Out? - Investor's Business Daily

Amgen (AMGN) stock pulled back in after-hours trading Tuesday as several key products saw sales declines, outweighing an overall beat-and-raise. The S&P 500 biotech company earned an adjusted $6…